166 related articles for article (PubMed ID: 4142466)
21. Tumor-secific immunity to chemically induced tumors. Evidence for immunologic specificity and shared antigenicity in lymphocyte responses to soluble tumor antigens.
Frbes JT; Nakaw Y; Smith RT
J Exp Med; 1975 May; 141(5):1181-200. PubMed ID: 47896
[TBL] [Abstract][Full Text] [Related]
22. The immune response to virally determined tumor associated antigens.
Lamon EW
Biochim Biophys Acta; 1974 Sep; 355(2):149-76. PubMed ID: 4370470
[No Abstract] [Full Text] [Related]
23. A microassay for humoral cytotoxicity demonstrating sublethal effects of antibody.
Cleveland PH; McKhann CF; Johnson K; Nelson S
Int J Cancer; 1974 Sep; 14(3):417-26. PubMed ID: 4459274
[No Abstract] [Full Text] [Related]
24. Cell interactions in leukemia-associated immunosuppression: suppression of thymus-independent antibody responses by leukemia spleen cells (Moloney) in vitro is mediated by normal T cells.
Caulfield MJ; Cerny J
J Immunol; 1980 Jan; 124(1):255-60. PubMed ID: 6965291
[No Abstract] [Full Text] [Related]
25. Blocking of syngeneic effector T cells by soluble tumour antigens.
Plata F; Levy JP
Nature; 1974 May; 249(454):271-4. PubMed ID: 4545403
[No Abstract] [Full Text] [Related]
26. Tumor immunity in vivo: evidence that immune destruction of tumor leaves "bystander" cells intact.
Weissman IL
J Natl Cancer Inst; 1973 Aug; 51(2):443-8. PubMed ID: 4765368
[No Abstract] [Full Text] [Related]
27. Facilitation of tumor growth by syngeneic normal cells mixed with tumor cells in vitro.
Deckers PJ; Ramming KP; Pilch YH
Cancer; 1971 Apr; 27(4):897-901. PubMed ID: 5574078
[No Abstract] [Full Text] [Related]
28. Secondary in vitro generation of cytolytic T-lymphocytes (CTL's) in the murine sarcoma virus system. Virus-specific CTL induction across the H-2 barrier.
Collavo D; Parenti A; Biasi G; Chieco-Bianchi L; Colombatti A
J Natl Cancer Inst; 1978 Sep; 61(3):885-90. PubMed ID: 80457
[TBL] [Abstract][Full Text] [Related]
29. Genetic control of in vivo immunity to tumor-specific transplantation antigens of chemically induced murine fibrosarcomas.
Parmiani G; Ballinari D
Int J Cancer; 1979 May; 23(5):697-705. PubMed ID: 88423
[No Abstract] [Full Text] [Related]
30. Cytotoxic T lymphocytes to murine plasmacytoma cells in allogeneic and syngeneic mice: H-2 antigens are essential in the induction and effector stages of CTL.
Kaneko Y; Natsuume-Sakai S; Migita S
J Immunol; 1978 Aug; 121(2):427-37. PubMed ID: 79604
[No Abstract] [Full Text] [Related]
31. Evidence of suppressor cell activity in spleens of mice bearing primary tumors induced by Moloney sarcoma virus.
Kirchner H; Chused TM; Herberman RB; Holden HT; Lavrin DH
J Exp Med; 1974 Jun; 139(6):1473-87. PubMed ID: 4598016
[TBL] [Abstract][Full Text] [Related]
32. Topographical distribution and association of tumor--associated antigens and their role in antigenicity in rat tumor cells.
Moriuchi T
Hokkaido Igaku Zasshi; 1979 Sep; 54(5):487-99. PubMed ID: 93561
[TBL] [Abstract][Full Text] [Related]
33. Histocompatibility antigens and tumor-specific transplantation antigens.
Appella E; Law LW
Exp Cell Biol; 1976; 44(3-6):131-49. PubMed ID: 196952
[No Abstract] [Full Text] [Related]
34. Common transplantation antigens on methylcholanthrene-induced murine sarcomas detected by three assays of tumor rejection.
Leffell MS; Coggin JH
Cancer Res; 1977 Nov; 37(11):4112-9. PubMed ID: 908044
[No Abstract] [Full Text] [Related]
35. Specificity of homograft rejection in vivo, assessed by inoculation of artificially mixed compatible and incompatible tumor cells.
Klein E; Klein G
Cell Immunol; 1972 Sep; 5(1):201-8. PubMed ID: 5056574
[No Abstract] [Full Text] [Related]
36. Studies on immunity to autochthonous mouse tumors.
Hellström I; Hellström KE; Pierce GE; Fefer A
Transplant Proc; 1969 Mar; 1(1):90-4. PubMed ID: 5406848
[No Abstract] [Full Text] [Related]
37. Cytotoxicity against tumour-associated antigens not H-2 restricted.
Holden HT; Herberman RB
Nature; 1977 Jul; 268(5617):250-2. PubMed ID: 69992
[No Abstract] [Full Text] [Related]
38. Cell interactions in adoptive immune rejection of a syngeneic tumor.
Howell SB; Dean JH; Esber EC; Llaw LW
Int J Cancer; 1974 Nov; 14(5):662-74. PubMed ID: 4376531
[No Abstract] [Full Text] [Related]
39. Alteration of cell-surface antigenicity of the mouse plasmacytoma. I. Immunologic characterization of surface antigens masked during successive transplantations.
Ono S; Natsu-ume S; Migita S
J Natl Cancer Inst; 1975 Sep; 55(3):569-77. PubMed ID: 51090
[TBL] [Abstract][Full Text] [Related]
40. Cell-mediated reaction against tumors induced by oncornaviruses. I. Kinetics and specificity of the immune response in murine sarcoma virus (MSV)-induced tumors and transplanted lymphomas.
Leclerc JC; Gomard E; Levy JP
Int J Cancer; 1972 Nov; 10(3):589-601. PubMed ID: 4128690
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
